Spire Healthcare Group (LON:SPI) Trading 38.3% Higher – Should You Buy?

Spire Healthcare Group plc (LON:SPI)’s share price traded up 38.3% on Thursday . The company traded as high as GBX 215.50 and last traded at GBX 208.05. 52,664,664 shares were traded during mid-day trading, an increase of 1,295% from the average session volume of 3,776,149 shares. The stock had previously closed at GBX 150.40.

Key Spire Healthcare Group News

Here are the key news stories impacting Spire Healthcare Group this week:

• Positive Sentiment: Spire Healthcare received a takeover approach from Toscafund, valuing the company at around £1 billion, which could imply a significant premium for shareholders. Reuters: London’s Spire Healthcare gets $1.35 billion buyout proposal from Toscafund
• Positive Sentiment: Spire Healthcare said it would support the proposed £1 billion bid from Toscafund, increasing investor confidence that a deal could move forward. Spire Healthcare says would back GBP1 billion bid from Toscafund
• Positive Sentiment: Deutsche Bank reaffirmed its buy rating on Spire Healthcare and set a GBX 245 price target, reinforcing a bullish view on the shares. Broker view update via Sharecast/Digital Look
• Positive Sentiment: Spire also confirmed its full-year outlook and said private revenue has grown strongly, while maintaining 2026 earnings guidance after stable early-year trading. Spire Healthcare confirms full-year outlook
• Neutral Sentiment: Shareholders gave strong backing to management at the 2026 AGM, approving all resolutions, which supports governance stability but is not a direct earnings catalyst. Spire Healthcare Wins Strong Shareholder Backing at 2026 AGM

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 245 price objective on shares of Spire Healthcare Group in a research note on Friday. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, Spire Healthcare Group currently has a consensus rating of “Buy” and a consensus price target of GBX 276.

Spire Healthcare Group Price Performance

The stock has a market cap of £911.36 million, a P/E ratio of 56.88, a price-to-earnings-growth ratio of 1.06 and a beta of 0.91. The company has a current ratio of 0.63, a quick ratio of 0.74 and a debt-to-equity ratio of 177.14. The company’s fifty day simple moving average is GBX 164.39 and its 200-day simple moving average is GBX 185.82.

Spire Healthcare Group (LON:SPI) last announced its quarterly earnings results on Friday, March 6th. The company reported GBX 9.60 earnings per share (EPS) for the quarter. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%. As a group, sell-side analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.